Literature DB >> 33686899

Diabetes Insipidus and Concomitant Myocarditis: A Late Sequelae of COVID-19 Infection.

Abu Baker Sheikh1, Nismat Javed2, Abdul Ahad Ehsan Sheikh3, Shubhra Upadhyay1, Rahul Shekhar4.   

Abstract

Severe acute respiratory syndrome coronavirus 2 causes coronavirus disease 2019 (COVID-19), which has become a global pandemic. Apart from the mild features of the disease, long-term complications involve many systems including both endocrine and cardiovascular systems. Myocarditis, secondary to COVID-19, has become a well-known complication of the disease. However, endocrine complications are generally not common, particularly isolated pituitary abnormalities. There is one other report of diabetes insipidus developing as a late sequela of COVID-19. In this article, we report a case of a young male who presented with features of myocarditis but developed diabetes insipidus on day 7 of admission as a long-term complication after recovery from COVID-19 infection. His laboratory test results at the time of developing the complication revealed a high serum sodium level and low urine osmolality. The patient recovered on administration of desmopressin and was discharged after 16 days of hospitalization.

Entities:  

Keywords:  COVID-19; complication; diabetes insipidus; myocarditis

Year:  2021        PMID: 33686899     DOI: 10.1177/2324709621999954

Source DB:  PubMed          Journal:  J Investig Med High Impact Case Rep        ISSN: 2324-7096


  8 in total

Review 1.  Case Report: Hypothalamic Amenorrhea Following COVID-19 Infection and Review of Literatures.

Authors:  Paolo Facondo; Virginia Maltese; Andrea Delbarba; Ilenia Pirola; Mario Rotondi; Alberto Ferlin; Carlo Cappelli
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-10       Impact factor: 6.055

2.  Central Diabetes Insipidus Following Immunization With BNT162b2 mRNA COVID-19 Vaccine: A Case Report.

Authors:  Bruno Bouça; Marisa Roldão; Paula Bogalho; Luís Cerqueira; José Silva-Nunes
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-04       Impact factor: 6.055

3.  Central diabetes insipidus secondary to COVID-19 infection: a case report.

Authors:  Ali Yavari; Zahra Sharifan; Bagher Larijani; Ali Mosadegh Khah
Journal:  BMC Endocr Disord       Date:  2022-05-19       Impact factor: 3.263

Review 4.  COVID-19 and hypopituitarism.

Authors:  Stefano Frara; Paola Loli; Agnese Allora; Chiara Santini; Luigi di Filippo; Pietro Mortini; Maria Fleseriu; Andrea Giustina
Journal:  Rev Endocr Metab Disord       Date:  2021-08-13       Impact factor: 9.306

5.  COVID-19 Infection and Myocarditis: A State-of-the-Art Systematic Review.

Authors:  Vikash Jaiswal; Zouina Sarfraz; Azza Sarfraz; Dattatreya Mukherjee; Nitya Batra; Gazala Hitawala; Sadia Yaqoob; Abhinav Patel; Preeti Agarwala; Muzna Sarfraz; Shehar Bano; Nishwa Azeem; Sidra Naz; Akash Jaiswal; Prachi Sharma; Gaurav Chaudhary
Journal:  J Prim Care Community Health       Date:  2021 Jan-Dec

Review 6.  COVID-19 and the Endocrine System: A Review of the Current Information and Misinformation.

Authors:  Samir Ahmed Mirza; Abdul Ahad Ehsan Sheikh; Michaela Barbera; Zainab Ijaz; Muhammad Ali Javaid; Rahul Shekhar; Suman Pal; Abu Baker Sheikh
Journal:  Infect Dis Rep       Date:  2022-03-11

7.  Central diabetes insipidus (Infundibuloneuro hypophysitis): A late complication of COVID-19 infection.

Authors:  R A Misgar; A Rasool; A I Wani; M I Bashir
Journal:  J Endocrinol Invest       Date:  2021-07-03       Impact factor: 4.256

Review 8.  Vasopressin and Its Analogues: From Natural Hormones to Multitasking Peptides.

Authors:  Mladena Glavaš; Agata Gitlin-Domagalska; Dawid Dębowski; Natalia Ptaszyńska; Anna Łęgowska; Krzysztof Rolka
Journal:  Int J Mol Sci       Date:  2022-03-12       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.